Catalyst Wire Dossier Catalyst Wire Dossier

Gonadotropin-releasing hormone agonist (GnRHa)

Gonadotropin-releasing hormone agonist
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gonadotropin-releasing hormone agonist (GnRHa), covering 2026-04-16 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires

See pricing